ArticleScientific reports2025
On the analyses of graphene oxide/polypyrrole/zinc oxide nanocomposites.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Molecular modeling characterization of cellulose and chitosan metal oxide hybrid interfaces.Scientific reports · 2026Article
- Electronic and structural properties of ZnO, Fe₂O₃, and Al₂O₃ clusters interacted with graphene oxide: a combined DFT and experimental study.Scientific reports · 2026Article
- Modulating the Electronic Structure and Global Reactivity of Nitrogen/Boron Co-Doped Graphene Oxide: A Density Functional Theory Study for Enhanced Gas Sensing Applications.Molecules (Basel, Switzerland) · 2026Article
- Modeling ZnScientific reports · 2026Article
- Density Functional Theory Insights into Polypyrrole-Based Functional Composites for Advanced Energy Storage, Sensing, and Environmental Applications.Nanomaterials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Graphene oxide/Polypyrrole/Zinc oxide GrO/PPy/ZnO nanocomposite was investigated for possible interaction with alanine using B3LYP/LANL2DZ model. Results indicated that GrO/PPy/ZnO exhibited notable electronic accessibility with a total dipole moment (TDM) of 5.62 Debye and HOMO-LUMO energy gap of 1.64 eV, which was significantly modulated upon alanine binding. COOH functionalization induced the greatest reduction in ionization potential (from 3.03 eV to 2.56 eV) alongside increased electron affinity (4.68 to 4.77 eV), while NH₂ functionalization showed moderate improvements (ionization potential to 2.67 eV, electron affinity to 4.75 eV). Quantum Theory of Atoms in Molecules (QTAIM) analysis revealed distinct binding characteristics: NH₂-bound systems formed multiple Zn-N and Zn-O coordination bonds with flexible interaction networks, while COOH-bound systems exhibited fewer but stronger, more localized coordination and hydrogen bonds. Molecular electrostatic potential (MESP) demonstrated enhanced positive potential near NH₂ binding sites and pronounced dipolar features around COOH regions. Non-covalent interaction (NCI) and reduced density gradient (RDG) analyses revealed that COOH functionalization produced more concentrated blue domains, indicating stronger interactions and enhanced selectivity. Density of states (DOS) showed notable band gap reduction after composite formation and functionalization, with GrO/PPy/ZnO exhibiting the most favorable electronic structure for charge transport. Alanine binding lowered system polarity (TDM: 2.81 Debye for COOH and 2.77 D for NH₂) while preserving structural stability, as shown by slight changes in chemical hardness. Overall, COOH-functionalized GrO/PPy/ZnO shows the best balance of reactivity, stability, and selective binding, with favorable electrostatics and strong interactions, highlighting its promise as an efficient amino acid sensor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.